X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (17) 17
index medicus (13) 13
female (12) 12
oncology (12) 12
aged (11) 11
middle aged (11) 11
male (10) 10
adult (8) 8
colorectal cancer (8) 8
colorectal neoplasms - drug therapy (8) 8
mutation (8) 8
chemotherapy (6) 6
metastasis (6) 6
research (6) 6
tumors (6) 6
aged, 80 and over (5) 5
cancer (5) 5
cancer therapies (5) 5
colorectal neoplasms - genetics (5) 5
neoplasm metastasis (5) 5
settore med/06 - oncologia medica (5) 5
antineoplastic agents - therapeutic use (4) 4
antineoplastic combined chemotherapy protocols - therapeutic use (4) 4
article (4) 4
clinical trials (4) 4
colorectal neoplasms - pathology (4) 4
disease-free survival (4) 4
genetic aspects (4) 4
hematology, oncology and palliative medicine (4) 4
medical prognosis (4) 4
retrospective studies (4) 4
review (4) 4
treatment outcome (4) 4
acquired-resistance (3) 3
biomarkers, tumor - genetics (3) 3
cetuximab (3) 3
colorectal neoplasms - metabolism (3) 3
colorectal neoplasms - mortality (3) 3
double-blind method (3) 3
drug resistance, neoplasm - drug effects (3) 3
gene copy number (3) 3
growth-factor receptor (3) 3
oxaliplatin (3) 3
panitumumab (3) 3
patient selection (3) 3
patients (3) 3
phenylurea compounds - therapeutic use (3) 3
proteins (3) 3
receptor, erbb-2 - genetics (3) 3
survival analysis (3) 3
therapy (3) 3
1506 (2) 2
1st-line treatment (2) 2
abridged index medicus (2) 2
american-society (2) 2
anemia - chemically induced (2) 2
anemia - drug therapy (2) 2
animals (2) 2
antibodies, monoclonal - administration & dosage (2) 2
antibodies, monoclonal - pharmacology (2) 2
antibodies, monoclonal - therapeutic use (2) 2
antibodies, monoclonal, humanized (2) 2
antimitotic agents (2) 2
antineoplastic agents (2) 2
antineoplastic agents - adverse effects (2) 2
antineoplastic agents - pharmacology (2) 2
antineoplastic combined chemotherapy protocols - adverse effects (2) 2
biomarkers (2) 2
biomarkers, tumor - analysis (2) 2
biomarkers, tumor - blood (2) 2
breast (2) 2
cancer patients (2) 2
class i phosphatidylinositol 3-kinases (2) 2
codon (2) 2
colon (2) 2
colony-stimulating factor (2) 2
colorectal neoplasms - blood (2) 2
colorectal-cancer (2) 2
combination (2) 2
deoxyribonucleic acid--dna (2) 2
development and progression (2) 2
diagnosis (2) 2
digestive system diseases (2) 2
dna sequencing (2) 2
dna, neoplasm - blood (2) 2
double-blind (2) 2
drug resistance, neoplasm - genetics (2) 2
drug therapy (2) 2
egfr (2) 2
filgrastim (2) 2
follow-up studies (2) 2
genetic research (2) 2
genetics & heredity (2) 2
granulocyte colony-stimulating factor (2) 2
granulocyte colony-stimulating factor - administration & dosage (2) 2
health aspects (2) 2
identification (2) 2
internal medicine (2) 2
irinotecan (2) 2
kaplan-meier estimate (2) 2
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Lancet, The, ISSN 0140-6736, 2014, Volume 384, Issue 9940, pp. 319 - 328
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 8, pp. 937 - 948
Summary Background Tumour mutational status is an important determinant of the response of metastatic colorectal cancer to targeted treatments. However, the... 
Hematology, Oncology and Palliative Medicine | KRAS MUTATIONS | 1ST-LINE TREATMENT | LEUCOVORIN | PLUS IRINOTECAN | ONCOLOGY | RANDOMIZED PHASE-III | INHIBITS GROWTH | ACQUIRED-RESISTANCE | FLUOROURACIL | PLACEBO PLUS | TUMOR-GROWTH | Predictive Value of Tests | Proto-Oncogene Proteins p21(ras) | Colorectal Neoplasms - genetics | Humans | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Clinical Trials, Phase III as Topic | Time Factors | DNA Mutational Analysis | Colorectal Neoplasms - drug therapy | Real-Time Polymerase Chain Reaction | Precision Medicine | Receptor, TIE-1 - blood | Phosphatidylinositol 3-Kinases - blood | Genetic Predisposition to Disease | Adenocarcinoma - blood | ras Proteins - blood | Adenocarcinoma - drug therapy | Adenocarcinoma - secondary | Disease Progression | Phenotype | Class I Phosphatidylinositol 3-Kinases | Biomarkers, Tumor - genetics | ras Proteins - genetics | Patient Selection | DNA, Neoplasm - blood | Female | Adenocarcinoma - genetics | Retrospective Studies | Pyridines - therapeutic use | Colorectal Neoplasms - mortality | Colorectal Neoplasms - blood | Kaplan-Meier Estimate | Proportional Hazards Models | Phenylurea Compounds - therapeutic use | Proto-Oncogene Proteins B-raf - blood | Proto-Oncogene Proteins - genetics | Treatment Outcome | Randomized Controlled Trials as Topic | Biomarkers, Tumor - blood | Phosphatidylinositol 3-Kinases - genetics | Disease-Free Survival | Proto-Oncogene Proteins B-raf - genetics | Aged | DNA, Neoplasm - genetics | Colorectal Neoplasms - pathology | Proto-Oncogene Proteins - blood | Adenocarcinoma - mortality | Medical colleges | Medical research | Cancer patients | Prognosis | Liver | DNA | Colorectal cancer | Genetic research | Medicine, Experimental | Metastasis
Journal Article
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 6, pp. 738 - 746
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2010, Volume 11, Issue 8, pp. 753 - 762
Journal Article
Nature, ISSN 0028-0836, 10/2015, Volume 526, Issue 7572, pp. 263 - 267
Colorectal cancer is the third most common cancer worldwide, with 1.2 million patients diagnosed annually. In late-stage colorectal cancer, the most commonly... 
PANITUMUMAB | THERAPY | MULTIDISCIPLINARY SCIENCES | SEQUENCE | ACQUIRED-RESISTANCE | SOMATIC MUTATION | IDENTIFICATION | GENE COPY NUMBER | ACTIVATING MUTATIONS | BREAST | INSIGHTS | Receptor, Epidermal Growth Factor - genetics | Receptor, ErbB-2 - genetics | Proto-Oncogene Proteins p21(ras) - genetics | Colorectal Neoplasms - genetics | Genomics | Humans | Antibodies, Monoclonal - therapeutic use | Antineoplastic Agents - therapeutic use | Cetuximab - therapeutic use | Molecular Targeted Therapy | Receptor, Fibroblast Growth Factor, Type 1 - genetics | MAP Kinase Kinase 1 - genetics | Colorectal Neoplasms - drug therapy | Female | Antineoplastic Agents - pharmacology | Insulin Receptor Substrate Proteins - genetics | Colorectal Neoplasms - metabolism | Antibodies, Monoclonal - pharmacology | Cetuximab - pharmacology | DNA Copy Number Variations - genetics | Mutation - genetics | Genome, Human - genetics | Receptor, Epidermal Growth Factor - chemistry | Xenograft Model Antitumor Assays | Drug Resistance, Neoplasm - genetics | Exome - genetics | Animals | Receptor, Platelet-Derived Growth Factor alpha - genetics | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Mice | Drug Resistance, Neoplasm - drug effects | Care and treatment | Gene mutations | Colorectal cancer | Drug metabolism | Genetic aspects | Identification and classification | Health aspects | Proteins | Epidermal growth factor | Genes | Clinical trials | Mutation | Kinases | Cancer therapies | Tumors
Journal Article
Journal of Endourology, ISSN 0892-7790, 09/2017, Volume 31, Issue S2, pp. P1 - A474
Journal Article
Journal Article
Science Translational Medicine, ISSN 1946-6234, 02/2014, Volume 6, Issue 224, pp. 224ra24 - 224ra24
The development of noninvasive methods to detect and monitor tumors continues to be a major challenge in oncology. We used digital polymerase chain... 
Humans | Middle Aged | Male | Young Adult | Neoplasm Metastasis | Neoplasms - blood | DNA, Neoplasm - blood | Neoplasms - genetics | Aged, 80 and over | Adult | Female | Aged | Neoplasms - pathology | MEDICINE, RESEARCH & EXPERIMENTAL | CELL BIOLOGY | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article